TradingKey

TradingKey - CoreWeave's share price has continued to weaken recently. On Wednesday, the company's stock fell another 3.5%, marking its fifth consecutive trading day of losses, with a cumulative decline of over 14% across the five sessions.

TradingKey - On June 12, Eastern Time, SpaceX (SPCX) debuted on the Nasdaq at $135 per share. In the following trading sessions, the stock price surged to a high of $225.64, with its market capitalization approaching $3 trillion. However, on July 15, the stock price fell below its $135 IPO offering price for the first time during intraday trading, reaching a low of $132.15, before closing at $135.27 to narrowly hold the level.

Japanese and South Korean stock markets plummeted, erasing earlier gains. The KOSPI dropped more than 6%, and the Nikkei 225 fell over 2%. Kioxia plunged 15%, SK Hynix slumped 11%, while Samsung Electronics and SoftBank followed the decline.

TradingKey - On July 16, Eastern Time, TSMC (TSM) released its second-quarter 2026 financial results. The company's revenue for the quarter reached TWD 1.27 trillion, up 36.0% year-on-year and 12.0% quarter-on-quarter. In US dollar terms, revenue was USD 40.2 billion, representing a 33.7% year-on-year increase and reaching the upper end of the previous guidance range of USD 39.0 billion to USD 40.2 billion.

TradingKey - As of July 15 Eastern Time, ASML US ADRs were priced at $1,815.27, rising 2.23% on the day and reaching an intraday high of $1,830. ASML's stock price strengthened significantly following the release of its earnings report, primarily because the company's second-quarter results exceeded market expectations and it raised its full-year revenue guidance once again.

With Solana holding key support near $78, is the $100 target for H2 2026 still on the table? Read our expert SOL price prediction and market analysis.

TradingKey - On July 15 (ET), ASML, the world’s largest photolithography machine manufacturer, stated that as demand for advanced chipmaking equipment continues to grow, the company has room to further increase prices for some of its products. ASML CFO Roger Dassen noted that the current market environment provides a favorable opportunity for equipment price hikes. The company is currently discussing pricing with customers, though specific increase magnitudes and implementation timelines have not yet been announced.

TradingKey - Is it finally the pickaxe sellers' moment? As HBM ramps, U.S. fabs break ground, and advanced packaging scales up, the investment case for semiconductor equipment stocks is quietly shifting.

Micron fell 7% on July 15 as China’s CXMT announced an $8.5B IPO and the US government considered new HBM export restrictions. At $904, the 50-day EMA and $869 support are all that stand between bulls and a deeper drop. KeyBanc says buy it.

The Bank of Korea's rate hike announcement triggered a stock market sell-off, with the KOSPI dropping 6%, Samsung Electronics falling over 8%, and SK Hynix plunging more than 11%.

TradingKey - On July 15 ET, the three major U.S. stock indices closed higher for the second consecutive trading session. An unexpected decline in the U.S. June PPI further reinforced expectations of cooling inflation, while the start of the corporate earnings season continued to exceed market expect

PayPal is at $55.41 on day two after the Stripe-Advent $60.50 bid drove a 17% surge. Polymarket prices an 82% deal probability. RSI near 80 is overbought. Here’s why $52.22 is the floor and $57.50 is the next decision point.

Japanese and South Korean stock markets opened sharply lower, with the KOSPI Index plunging 5% and the Nikkei 225 falling over 2%. SK Hynix led the decline with a drop of more than 9%, while Samsung Electronics, Kioxia, and SoftBank also followed the downward trend.

• Telecom infrastructure recovery delays and inventory digestion are suppressing Lumentum’s revenue growth. • Increased competition in 3D sensing and industrial lasers is pressuring Lumentum's pricing power. • The stock remains volatile as market participants await clear signals of cyclical recovery.

• Bristol Myers Squibb rose due to positive late-stage clinical trial results. • Increased institutional inflows support the company's defensive pharmaceutical sector valuation. • Technical indicators show a breakout, with a current MACD value of 0.322.

• Novo Nordisk shares rose on manufacturing expansion and obesity treatment clinical milestones. • Semaglutide therapeutic expansion into kidney disease and metabolic conditions attracted institutional capital. • Robust free cash flow and market dominance provide stability amid broader economic uncertainty.

• Ciena shares declined due to slower optical networking upgrades by major cloud service providers. • Analysts lowered price targets amid concerns regarding pricing pressure and global macroeconomic uncertainty. • Technical indicators currently signal neutral market conditions for Ciena Corporation stock.

• Elevance Health shares declined due to rising medical loss ratios and healthcare utilization rates. • Higher specialty pharmacy and orthopedic surgery costs forced reassessment of full-year margin targets. • Stringent CMS reimbursement policies and regulatory pressures negatively impact long-term margin outlooks.

TradingKey - US inflation data continued to cool, boosting market expectations that the Federal Reserve will not need to raise interest rates significantly this year. The three major US stock indices all finished higher as mega-cap tech stocks strengthened, though chip and memory stocks faced a market sell-off. At the close, the Dow Jones Industrial Average rose 0.29% to 52,658.64 points; the Nasdaq Composite Index gained 0.62% to 26,269.23 points; and the S&P 500 Index climbed 0.38% to 7,572.40 points.

• UK interest rate trends support resilient net interest margins for NatWest Group. • Investors anticipate increased capital returns through share buybacks and dividend payouts. • Operational efficiency and stabilizing domestic lending markets enhance the bank's financial outlook.